216 related articles for article (PubMed ID: 26202443)
1. Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis.
Kalkan A; Hallert E; Carlsson P; Roback K; Sjöwall C
Scand J Rheumatol; 2015; 44(4):265-70. PubMed ID: 26202443
[TBL] [Abstract][Full Text] [Related]
2. Variations and practice in the care of patients with rheumatoid arthritis: quality and cost of care.
DeMaria L; Acelajado MC; Luck J; Ta H; Chernoff D; Florentino J; Peabody JW
J Clin Rheumatol; 2014 Mar; 20(2):79-86. PubMed ID: 24561410
[TBL] [Abstract][Full Text] [Related]
3. A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice.
Nicholls D; Zochling J; Boers A; Champion G; Mathers D; Riordan J; Youssef P; Scott J; Griffiths H
Int J Rheum Dis; 2014 Sep; 17(7):755-61. PubMed ID: 24131467
[TBL] [Abstract][Full Text] [Related]
4. Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.
Kalkan A; Husberg M; Hallert E; Roback K; Thyberg I; Skogh T; Carlsson P
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1679-85. PubMed ID: 26097219
[TBL] [Abstract][Full Text] [Related]
5. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population.
McCarthy EM; Azeez MA; Fitzpatrick FM; Donnelly S
J Clin Rheumatol; 2012 Aug; 18(5):237-41. PubMed ID: 22832287
[TBL] [Abstract][Full Text] [Related]
7. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
8. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
[TBL] [Abstract][Full Text] [Related]
9. Investigation on Brazilian clinical practices in rheumatoid arthritis: the Brazilian rheumatoid arthritis clinical practices investigation--BRACTICE.
Helfenstein M; Halpern AS; Bertolo MB
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 1):S1-10. PubMed ID: 21654277
[TBL] [Abstract][Full Text] [Related]
10. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
11. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
Criswell LA; Henke CJ
J Rheumatol; 1995 May; 22(5):829-35. PubMed ID: 8587068
[TBL] [Abstract][Full Text] [Related]
12. Treating rheumatoid arthritis to target: a Canadian patient survey.
Haraoui B; Bensen W; Thorne C; Wade J; Deamude M; Prince J; Légaré J
J Clin Rheumatol; 2014 Mar; 20(2):61-7. PubMed ID: 24561407
[TBL] [Abstract][Full Text] [Related]
13. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.
Kalkan A; Roback K; Hallert E; Carlsson P
Implement Sci; 2014 Oct; 9():153. PubMed ID: 25304517
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis.
Meyfroidt S; van Hulst L; De Cock D; Van der Elst K; Joly J; Westhovens R; Hulscher M; Verschueren P
Scand J Rheumatol; 2014; 43(4):265-72. PubMed ID: 24559216
[TBL] [Abstract][Full Text] [Related]
16. How do French rheumatologists treat early rheumatoid arthritis?
de Asit N; Le Loët X; Czernichow P; Bertho JM; Delcambre B; Tonnel F; Loyau G; Dapogny C; Trèves R; Valat JP; Tauveron P; Sebert JL; Boumier P
Rev Rhum Engl Ed; 1996 Mar; 63(3):188-95. PubMed ID: 8731236
[TBL] [Abstract][Full Text] [Related]
17. Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness.
Suarez-Almazor ME; Soskolne CL; Saunders LD; Russell AS
J Rheumatol; 1995 May; 22(5):836-43. PubMed ID: 8587069
[TBL] [Abstract][Full Text] [Related]
18. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
Kamata Y; Minota S
Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
Nash P; Nicholls D
Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
[TBL] [Abstract][Full Text] [Related]
20. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
